Oramed Pharmaceuticals Inc. (ORMP.TA)
ILA 879.9
(4.22%)
ILA 879.9
(4.22%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 | -139.24 Million USD | 43.34% |
| 2021 | -245.76 Million USD | -281.48% |
| 2020 | -64.42 Million USD | -448.11% |
| 2019 | -11.75 Million USD | 34.64% |
| 2018 | -17.98 Million USD | -25.82% |
| 2017 | -14.29 Million USD | 3.69% |
| 2016 | -14.84 Million USD | -16.82% |
| 2015 | -12.7 Million USD | -101.94% |
| 2014 | -6.29 Million USD | 23.54% |
| 2013 | -8.22 Million USD | 53.74% |
| 2012 | -17.78 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q3 | 269.48 Million USD | 1300.53% |
| 2023 Q2 | -22.44 Million USD | 73.27% |
| 2023 Q1 | -83.98 Million USD | 39.69% |
| 2022 Q2 | -101.09 Million USD | -17.67% |
| 2022 Q1 | -85.91 Million USD | -0.84% |
| 2022 Q3 | -115.08 Million USD | -13.84% |
| 2022 Q4 | -139.24 Million USD | -20.99% |
| 2022 FY | -139.24 Million USD | 43.34% |
| 2021 Q2 | -184.69 Million ILA | -67.94% |
| 2021 Q1 | -109.97 Million USD | -132.84% |
| 2021 FY | -245.76 Million USD | -281.48% |
| 2021 Q3 | -245.76 Million USD | -33.07% |
| 2021 Q4 | -85.2 Million USD | 65.33% |
| 2020 Q2 | -32.7 Million USD | -58.77% |
| 2020 FY | -64.42 Million USD | -448.11% |
| 2020 Q1 | -20.59 Million USD | -86.86% |
| 2020 Q3 | -64.72 Million USD | -97.92% |
| 2020 Q4 | -47.23 Million USD | 27.02% |
| 2019 Q4 | -11.02 Million USD | 6.32% |
| 2019 Q3 | -11.76 Million USD | 17.75% |
| 2019 FY | -11.75 Million USD | 34.64% |
| 2019 Q2 | -14.3 Million USD | -15.11% |
| 2019 Q1 | -12.42 Million USD | 13.43% |
| 2018 Q1 | -11.45 Million USD | -160.67% |
| 2018 Q2 | -13.09 Million USD | -14.27% |
| 2018 FY | -17.98 Million USD | -25.82% |
| 2018 Q4 | -14.35 Million USD | 20.3% |
| 2018 Q3 | -18.01 Million USD | -37.56% |
| 2017 Q3 | -14.22 Million USD | -131.9% |
| 2017 Q2 | -6.13 Million USD | -16.03% |
| 2017 Q1 | -5.28 Million USD | 39.74% |
| 2017 FY | -14.29 Million USD | 3.69% |
| 2017 Q4 | -4.39 Million USD | 69.1% |
| 2016 Q1 | -12.62 Million USD | -67.25% |
| 2016 FY | -14.84 Million USD | -16.82% |
| 2016 Q4 | -8.77 Million USD | 40.54% |
| 2016 Q3 | -14.75 Million USD | -15.94% |
| 2016 Q2 | -12.72 Million USD | -0.82% |
| 2015 FY | -12.7 Million USD | -101.94% |
| 2015 Q3 | -12.63 Million USD | 15.21% |
| 2015 Q1 | -4.38 Million USD | 83.08% |
| 2015 Q2 | -14.89 Million USD | -239.4% |
| 2015 Q4 | -7.54 Million USD | 40.25% |
| 2014 Q3 | -6.29 Million USD | 26.79% |
| 2014 Q4 | -25.93 Million USD | -312.29% |
| 2014 FY | -6.29 Million USD | 23.54% |
| 2014 Q2 | -8.59 Million USD | 24.24% |
| 2014 Q1 | -11.34 Million USD | -134.81% |
| 2013 Q4 | -4.83 Million USD | 41.29% |
| 2013 Q3 | -8.22 Million USD | -101.74% |
| 2013 Q1 | -7.57 Million USD | 64.09% |
| 2013 FY | -8.22 Million USD | 53.74% |
| 2013 Q2 | -4.07 Million USD | 46.14% |
| 2012 Q3 | -17.78 Million USD | 0.0% |
| 2012 FY | -17.78 Million USD | 0.0% |
| 2012 Q4 | -21.08 Million USD | -18.56% |
| Name | Net Debt | Net Debt Difference |
|---|